metaPreg - Betaxolol (versus unexposed) during pregnancy

Betaxolol (versus unexposed) updated on 12-17-2024

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
2 non statistically significant endpoints reported in only one study
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Low birth weight (< 2500g)	5.72 [3.95, 8.28]	-	1 study		39	not evaluable	ROB	10.92 [7.37; .]
Preterm (< 37 weeks)	2.82 [1.82, 4.37]	-	1 study		24	not evaluable	ROB	5.09 [3.04; .]
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	2.89 [2.08, 4.02]	-	1 study		67	not evaluable	ROB	5.23 [3.58; .]
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
1 non statistically significant endpoints reported in only one study